9+ hour, 46+ min ago  (185+ words) Computational and preclinical data support advancement of LTS-201 and LTS-101 programs into clinic later this year Latus founder Beverly Davidson, Ph. D. , awarded the ASGCT Outstanding Achievement Award " the Society's highest honor Title: A computational framework for understanding the therapeutic potential…...

13+ hour, 41+ min ago  (1160+ words) New leadership and OEM momentum position the company for its next phase of commercialization at scale BOSTON--(BUSINESS WIRE)--Neurable, the leader in AI for noninvasive brain-computer interface (BCI) technology, today announced its official transition to a licensing platform model,…...

13+ hour, 20+ min ago  (200+ words) Partnership unlocks Olympia's established clinic network for Niagen Plus, expands pharmaceutical-grade Niagen supply chain, and brings liquid compounded vials to market "We anticipate that Olympia will play an important role in meeting the growing demand for Niagen IV and Niagen…...

19+ hour, 29+ min ago  (886+ words) Features company's patented Simpli Squeeze" valve for ready-to-dispense convenience, focused on reducing mess and drips CRYSTAL LAKE, Ill. --(BUSINESS WIRE)--Aptar Group, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced…...

1+ day, 19+ hour ago  (312+ words) SAN DIEGO--(BUSINESS WIRE)--$ARCT #Clinical Trial--Arcturus Therapeutics Holdings Inc. (the "Company, "Arcturus, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that it will release its financial…...

19+ hour, 52+ min ago  (664+ words) NEW YORK--(BUSINESS WIRE)--Ladenburg Thalmann & Co. Inc. (Ladenburg Thalmann), a leading middle-market investment bank providing investment banking, equity research, and institutional sales and trading services, today announced that Aydin Huseynov, M. D. , CFA, has joined the firm's Healthcare Investment Banking Group…...

1+ day, 5+ hour ago  (264+ words) Aviado Bio will combine its proprietary v Mi X" RNAi platform with Apertura's novel human Tf R1 capsid (Tf R1 Cap X") to enable one-time gene silencing in the central nervous system Aviado Bio will present key data on AVB-406 at the…...

1+ day, 5+ hour ago  (158+ words) Programmable circ RNA platform achieves near-complete B cell depletion in non-human primates using targeted in vivo CAR-T delivery BOSTON--(BUSINESS WIRE)--Strand Therapeutics, a clinical-stage biotechnology company pioneering programmable m RNA medicines, today announced it will present preclinical data from…...

1+ day, 6+ hour ago  (246+ words) - Oral presentation will highlight new interim clinical data from the ongoing POLARIS studies; additional posters showcase broader platform capabilities - The Presidential Symposium oral presentation will focus on ETX101, Encoded's precision gene-regulation therapy being developed as a one-time treatment for patients with…...

1+ day, 7+ hour ago  (454+ words) Oversubscribed round backed by existing shareholders Investment will support development of cardiovascular disease database to be used to inform patient stratification and therapeutic development programmes CAMBRIDGE, England--(BUSINESS WIRE)--Plaque Tec, a medtech company pioneering intracoronary liquid biopsy to identify…...